ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,716Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 1269

$778K Total Retail Price of All Prescriptions

Rank: 46 out of 1269

568 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 12,980 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 563 550 1 4
PRAVASTATIN SODIUM 524 514 2 11
AMLODIPINE BESYLATE 435 421 3 2
OMEPRAZOLE 423 403 4 8
LISINOPRIL 388 382 5 1
FUROSEMIDE 324 313 6 5
MIRTAZAPINE 285 285 7 24
DONEPEZIL HCL 281 281 8 22
METOPROLOL SUCCINATE 270 260 9 13
POTASSIUM CHLORIDE 249 236 10 26
GABAPENTIN 249 210 10 17
NAMENDA 228 221 12 38
LOSARTAN POTASSIUM 220 212 13 15
ATORVASTATIN CALCIUM 210 197 14 7
METOPROLOL TARTRATE 206 203 15 6
ISOSORBIDE MONONITRATE ER 204 193 16 63
ATENOLOL 196 185 17 14
TRAZODONE HCL 189 176 18 36
CITALOPRAM HBR 184 173 19 21
SERTRALINE HCL 153 148 20 23
WARFARIN SODIUM 153 136 20 12
POLYETHYLENE GLYCOL 3350 152 133 22 50
TRAMADOL HCL 145 135 23 16
PAROXETINE HCL 145 136 23 71
HYDRALAZINE HCL 143 143 25 48
METFORMIN HCL 125 104 26 9
DIGOXIN 119 117 27 62
CLOPIDOGREL 113 95 28 32
HYDROCHLOROTHIAZIDE 111 107 29 10
JANTOVEN 110 104 30 52
RANITIDINE HCL 106 83 31 27
QUETIAPINE FUMARATE 105 98 32 53
OXYCODONE-ACETAMINOPHEN 100 72 S2 33 44
HYDROCODONE-ACETAMINOPHEN 99 97 S3 34 20
DILTIAZEM 24HR ER 99 92 34 204
SIMVASTATIN 99 91 34 3
IPRATROPIUM-ALBUTEROL 98 98 37 86
TAMSULOSIN HCL 96 91 38 31
PANTOPRAZOLE SODIUM 88 83 39 18
CLONIDINE HCL 79 79 40 51
ALLOPURINOL 79 79 40 49
CRESTOR 77 76 42 25
CARVEDILOL 76 59 43 29
CARBIDOPA-LEVODOPA 76 76 43 78
CYMBALTA 74 67 45 70
ADVAIR DISKUS 73 66 46 46
ZOLPIDEM TARTRATE 71 70 47 19
CEPHALEXIN 71 68 47 113
GLIMEPIRIDE 68 60 49 57
TORSEMIDE 68 68 49 234
DIOVAN 67 67 51 35
AMOXICILLIN 66 54 52 129
PLAVIX 64 57 53 47
AZITHROMYCIN 63 55 54 42
AMOX TR-POTASSIUM CLAVULANATE 63 61 54 110
DIVALPROEX SODIUM 62 48 56 54
KLOR-CON M20 60 60 57 60
SYNTHROID 58 55 58 72
NITROSTAT 57 56 59 191
NOVOLOG 56 56 60 82
FENTANYL 55 55 S2 61 105
FLUTICASONE PROPIONATE 55 42 61 40
LOVASTATIN 52 48 63 30
PREDNISONE 52 52 63 45
FLUOXETINE HCL 52 52 63 83
PRIMIDONE 51 51 66 209
NEXIUM 51 48 66 41
SEROQUEL 51 48 66 104
DOXYCYCLINE HYCLATE 51 48 66 214
RISPERIDONE 50 50 70 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.